Bixiye
Attention Deficit [Hyperactivity] Disorder (ADHD/ADD) Agents - Commercial
Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2026
Natiijooyinka Raadinta
Soo bandhiga 4181 - 4190 ee natiijooyinka 4294
Bixiye
Vtama (tapinarof) - Commercial
Oggolaanshaha Hore
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2026
Bixiye
PCSK9 Inhibitors - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2026
Bixiye
Selective Serotonin Inverse Agonist (SSIA) - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2026
Bixiye
Hetlioz (tasimelteon) - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2026
Bixiye
Atypical Antipsychotics - Commercial
Step Therapy, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2026
Bixiye
Atypical Antipsychotics - Extended Maintenance Agents - Commercial
Step Therapy, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2026
Bixiye
Antidepressant Agents - Commercial
Step Therapy, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2026
Bixiye
Vtama (tapinarof) - Medicaid
Oggolaanshaha Hore
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2026
Bixiye
Zeposia (ozanimod) - Medicaid
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2026